.
.
why novartis� landmark cancer drug approval is great news for bluebird.daily pilot.
china's plans to import indian drugs fail to enthuse indian pharmaceutical firms
.the youngest claimant was aged 20, and the eldest aged 89, while the average policy duration at claim stage was 10 years..
may 17, 2018